Using genetic data to improve understanding of diseases
Leveraging long-range haplotypes in sequencing data to advance large scale genetic studies
This study is looking at how we can better understand the genes that cause human diseases, so that patients can get more accurate information about their genetics and potentially receive more personalized treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10653188 on NIH RePORTER |
What this research studies
This research focuses on enhancing the analysis of genetic data to better understand the genetic basis of human diseases. By leveraging advanced computational methods and large-scale genetic resources, the project aims to improve the accuracy of genetic variant identification and their association with diseases. Patients may benefit from improved genetic insights that could lead to better-targeted treatments and personalized medicine approaches. The research addresses challenges in analyzing genetic data, particularly in diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with genetic disorders or those interested in understanding their genetic predispositions to diseases.
Not a fit: Patients without any genetic disorders or those not interested in genetic testing may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate genetic testing and personalized treatment options for patients.
How similar studies have performed: Previous research has shown success in using genetic data to identify disease-related variants, making this approach promising and built on established methodologies.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zoellner, Sebastian — University of Michigan at Ann Arbor
- Study coordinator: Zoellner, Sebastian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.